Edition:
United States

People: Roche Holding AG (ROG.S)

ROG.S on Virt-X Level 1

279.00CHF
19 Jun 2019
Change (% chg)

CHF0.15 (+0.05%)
Prev Close
CHF278.85
Open
CHF278.95
Day's High
CHF279.40
Day's Low
CHF276.50
Volume
1,755,132
Avg. Vol
1,603,271
52-wk High
CHF280.55
52-wk Low
CHF209.00

Heuer, Michael 

Dr. Michael Heuer is no longer a Member of the Corporate Executive Committee, Interim Chief Executive Officer Roche Diagnostics at Roche Holding Ltd effective July 31st, 2019. He Heuer joined Boehringer Mannheim in 1983 and was appointed to his current position in 2018. Following the acquisition of Boehringer Mannheim by Roche in 1998, he held various management positions in sales, marketing and product development in Germany, Austria and the United States before being appointed Head of Roche's Near Patient Testing business unit. Prior to his current role, he was Head of Diagnostics Europe, Middle East, Africa and Latin America region. Michael Heuer holds a PhD in Chemistry from the University of Kiel.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Severin Schwan

11,760,500

Christoph Franz

5,745,700

Fritz Gerber

--

Andre Hoffmann

439,123

Alan Hippe

5,681,190

Cristina Wilbur

3,717,860
As Of  30 Dec 2018